Evidence map›Paper›PMID 37409618›Full record

ArticleCancer medicine2023

Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods.

Sravani Akula, Sai Charitha Mullaguri, Niklas Max Melton, Archana Katta, Venkata Sai Giridhar Reddy Naga, Shyamson Kandula, Raj Kumar Pedada, Janakiraman Subramanian, Rama Krishna Kancha

Abstract read
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sravani AkulaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Sai Charitha MullaguriMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Niklas Max MeltonThoracic Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA.
Archana KattaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Venkata Sai Giridhar Reddy NagaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Shyamson KandulaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Raj Kumar PedadaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Janakiraman SubramanianThoracic Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA.
Rama Krishna KanchaMolecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.ORCID 0000-0001-8146-1551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutations in kinases are the most frequent genetic alterations in cancer; however, experimental evidence establishing their cancerous nature is available only for a small fraction of these mutants.

aimsPredicition analysis of kinome mutations is the primary aim of this study. Further objective is to compare the performance of various softwares in pathogenicity prediction of kinase mutations. MATERIALS AND

methodsWe employed a set of computational tools to predict the pathogenicity of over forty-two thousand mutations and deposited the kinase-wise data in Mendeley database (Estimated Pathogenicity of Kinase Mutants [EPKiMu]).

resultsMutations are more likely to be drivers when being present in the kinase domain (vs. non-kinase domain) and belonging to hotspot residues (vs. non-hotspot residues). We identified that, while predictive tools have low specificity in general, PolyPhen-2 had the best accuracy. Further efforts to combine all four tools by consensus, voting, or other simple methods did not significantly improve accuracy. DISCUSSION: The study provides a large dataset of kinase mutations along with their predicted pathogenicity that can be used as a training set for future studies. Furthermore, a comparative sensitivity and selectivity of commonly used computational tools is presented.

conclusionPrimary-structure-based in silico tools identified more cancerous/deleterious mutations in the kinase domains and at the hot spot residues while having higher sensitivity than specificity in detecting deleterious mutations.

Indexed as

NeoplasmsSoftwareComputational BiologyHumansMutationSensitivity and SpecificityVirulencekinasepathogenicity predictionpoint mutationsprediction accuracysensitivity and specificity

Identifiers

PMID37409618
PMCPMC10501281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.